SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001326190-24-000038
Filing Date
2024-08-15
Accepted
2024-08-15 16:08:13
Documents
8
Period of Report
2024-09-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240926xdef14a.htm DEF 14A 760807
2 GRAPHIC tmb-20240926xdef14a_a001.jpg GRAPHIC 5607
3 GRAPHIC tmb-20240926xdef14a_a002.jpg GRAPHIC 4854
4 GRAPHIC tmb-20240926xdef14a_a003.jpg GRAPHIC 7501
5 GRAPHIC tmb-20240926xdef14a_a009.jpg GRAPHIC 29362
6 GRAPHIC tmb-20240926xdef14a_a010.jpg GRAPHIC 29236
7 GRAPHIC tmb-20240926xdef14a_bg001.jpg GRAPHIC 203365
8 GRAPHIC tmb-20240926xdef14a_bg002.jpg GRAPHIC 166686
  Complete submission text file 0001326190-24-000038.txt   1378243
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32587 | Film No.: 241212477
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)